Position
SIMPLEX TRADING, LLC in Cullinan Therapeutics, Inc.
Back to the book · All holders of CGEM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $51.2K$10.35 → $14.21
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.3K | $137.2K | — | — | — | 0.0% |
| Q1 2026 | 17.6K | $250.5K | $14.21 | $51.2K | $62.2K | 0.0% |